A review of update clinical results of carbon ion radiotherapy

Japanese Journal of Clinical Oncology

Volumn 42, Issue 8, 2012, Pages 670-685

  Tsujii, Hirohiko ^a   Kamada, Tadashi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Carbon ions; Dose distribution; Protons; Radiotherapy; Relative biological effectiveness

Indexed keywords

ANTINEOPLASTIC AGENT; DACARBAZINE; NIMUSTINE; VINCRISTINE;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; BILE DUCT CARCINOMA; BONE TUMOR; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHONDROSARCOMA; CHORDOMA; COMPUTER ASSISTED TOMOGRAPHY; ELECTRON THERAPY; ESOPHAGUS CANCER; EYE TUMOR; FAST NEUTRON RADIATION; FAST NEUTRON THERAPY; GENERAL PRACTICE; GIANT CELL TUMOR; HEAD AND NECK CANCER; HEAD AND NECK TUMOR; HELIUM ION RADIATION; HUMAN; ION THERAPY; LARGE CELL NEUROENDOCRINE CARCINOMA; LINEAR ENERGY TRANSFER; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MELANOMA; MENINGIOMA; MUCOSAL MALIGNANT MELANOMA; NONHUMAN; OSTEOSARCOMA; OVERALL SURVIVAL; OXYGEN ENHANCEMENT RATIO; PANCREAS CANCER; PARANASAL SINUS CANCER; PARANASAL SINUS TUMOR; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHOTON THERAPY; POSTOPERATIVE COMPLICATION; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; RADIATION INJURY REPAIR; RADIOBIOLOGY; RECTUM CANCER; REVIEW; SACRAL CHONDROMA; SACRAL SPINAL CORD; SALIVARY GLAND TUMOR; SKIN MANIFESTATION; SKULL BASE TUMOR; SOFT TISSUE DISEASE; SOFT TISSUE SARCOMA; SOFT TISSUE TUMOR; SPINE TUMOR; STOMACH CANCER; TOXICITY; UTERINE CERVIX CARCINOMA; X IRRADIATION;

CARBON; HUMANS; IONS; LINEAR ENERGY TRANSFER; NEOPLASM METASTASIS; NEOPLASMS; RADIOTHERAPY; RELATIVE BIOLOGICAL EFFECTIVENESS; TREATMENT OUTCOME;

EID: 84865079719     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hys104     Document Type: Review

References (128)

1. Suit HD, Westgate SJ. Impact of improved local control on survival. Int J Radiat Oncol Biol Phys 1986;12:453-8.
2. Chen GTY, Castro JR, Quivey JM. Heavy charged particle radiotherapy. Ann Rev Biophys Bioeng 1981;10:499-529.
3. Kanai T, Furusawa Y, Fukutsu K, et al. Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. Rad Res 1997;147:78-85.
4. Haberer T, Becher W, Schardt D, et al. Magnetic scanning system for heavy ion therapy. Nucl Instrum Methods 1993;A330:295-305.
5. Kraft G. Tumor therapy with heavy charged particles. Prog Part Nucl Phys 2000;45:S473-544.
6. Barendsen GW. RBE-LET relationships for lethal, potentially lethal and sublethal damage in mammalian cells: implications for fast neutron radiotherapy. Bull Cancer Radiother 1996;83(Suppl):15s-8s.
7. Skarsgard LD. Radiobiology with heavy charged particles: a historical review. Phys Med 1998;14(Suppl 1):1-19.
8. Tepper J, Verhey L, Goitein M, et al. In vivo determination of RBE in a high energy modulated proton beam using normal tissue reactions and fractionated dose schedules. Int J Radiat Oncol Biol Phys 1977;2:1115-22.
9. Goldstein LS, Phillips Ross GY. Biological effects of accelerated heavy ions. II. Fractionated irradiation of intestinal crypt cells. Rad Res 1981;86:542-58.
10. Raju MR, Carpenter BA. A heavy particle comparative study. Part IV: acute and late reactions. Br J Radiol 1978;51:720-7.
11. Ando K, Kase Y. Biological characteristics of carbon-ion therapy. Int J Radiat Biol 2009;85:715-28.
12. Battermann JJ, Breur K, Hart GAM, et al. Observation on pulmonary metastases in patients after single doses and multiple fractions of fast neutrons and Cobalt-60 gamma rays. Eur J Cancer 1981;17:539-48.
13. Laramore GE. The use of neutrons in cancer therapy: a historical perspective through the modern era. Semin Oncol 1997;24:672-85.
14. Denekamp J, Waites T, Fowler JF. Predicting realistic RBE values for clinically relevant radiotherapy schedules. Int J Radiat Biol 1997;71:681-94.
15. Ando K, Koike S, Uzawa A, et al. Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice. J Radiat Res 2005;46:51-7.
16. Tsujii H, Mizoe J, Kamada T, et al. Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol 2004;73(Suppl 2):S41-9.
17. Tsujii H, Kamada T, Baba M, et al. Clinical advantages of carbon-ion radiotherapy. New J Phys 2008;10:1367-2630.
18. Kamada T, Tsujii H. HIMAC: a new start for heavy ions. In: Linz U, editor. Ion Beam Therapy. Berlin, Heidelberg: Springer-Verlag 2012;611-21.
19. Ogata T, Teshima T, Kagawa K, et al. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res 2005;65:113-20.
20. Tamaki T, Iwakawa M, Ohno T, et al. Application of carbon-ion beams or gamma-rays on primary tumors does not change the expression profiles of metastatic tumors in an in vivo murine model. Int J Radiat Biol 2009;74:210-8.
21. Akino Y, Teshima T, Kihara A, et al. Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-small-cell lung cancer cells. Int J Radiat Biol 2009;75:475-81.
22. Minohara S, Kanai T, Endo M, et al. Respiratory gated irradiation system for heavy-ion radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1097-103.
23. Scholz M, Kellerer AM, Kraft-Weyrather W, et al. Computation of cell survival in heavy ion beams for therapy- the model and its approximation. Rad Environ Biohys 1997;36:59-66.
24. Endo M, Koyama-Ito H, Minohara S, et al. HIPLAN-a heavy ion treatment planning system at HIMAC. J Jpn Soc Ther Radiol Oncol 1996;8:231-8.
25. Castro JR. Results of heavy ion radiotherapy. Radiat Environ Biophys 1995;34:45-8.
26. Linstadt DE, Castro JR, Philips T. Neon ion radiotherapy: results of the phase I/II clinical trial. Int J Radiat Oncol Biol Phys 1991;20:761-9.
27. Combs S, Jaekel O, Haberer T, et al. Particle therapy at the Heidelberg Ion Therapy Center (HIT)-Integrated research-driven universityhospital-based radiation oncology service in Heidelberg, Germany. Radiother Oncol 2010;95:41-4.
28. Ohno T, Kanai T, Yamada S, et al. Carbon ion radiotherapy at the Gunma University Heavy Ion Medical Center: New Facility Set-up. Cancers 2011;3:4046-60.
29. Slater JD, Yonemoto LT, Mantik DW, et al. Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique. Int J Radiat Oncol Biol Phys 2005;62:494-500.
30. Chan AW, Pommier P, Deschler DG, et al. Change in patterns of relapse after combined proton and photon irradiation for locally advanced paranasal sinus cancer. Int J Radiat Oncol Biol Phys 2004;60(Suppl):S320.
31. Mizoe J, Tsujii H, Kamada T, et al. Dose escalation study of carbon ion radiotherapy for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2004;60:358-64.
32. Hasegawa A, Koto M, Takagi R, et al. Carbon ion radiotherapy for head and neck tumors. Proceedings of NIRS-ETOILE 2nd Joint Symposium on Carbon Ion Radiotherapy 2011, Centre ETOILE, Lyon, NIRS-M-243; 18-26.
33. Schulz-Ertner D, Nikoghosyan A, Didinger B, et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 2005;104:338-44.
34. Iseli TA, Karnell LH, Graham SM, et al. Role of radiotherapy in adenoid cystic carcinoma of the head and neck. J Laryngol Otol 2009;123:1137-44.
35. Mendenhall WM, Morris CG, Amdur RJ, et al. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck 2004;26:154-62.
36. Pommier P, Liebsch NJ, Deschler DG, et al. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:1242-9.
37. Huber PE, Debus J, Latz D, et al. Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam? Radiother Oncol 2001;59:161-7.
38. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base Report on cutaneous and noncutaneous melanoma. Cancer 1998;83:1664-78.
39. Patel SG, Prasad ML, Escrig M, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck 2002;24:247-57.
40. Lund VJ, Howard DJ, Harding L, et al. Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope 1999;109:208-11.
41. Yanagi T, Mizoe J, Hasegawa A, et al. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 2009;74:15-20.
42. Willers H, Hug EB, Spiro IJ, et al. Adult soft tissue sarcomas of the head and neck treated by radiation and surgery or radiation alone: patterns of failure and prognostic factors. Int J Radiat Oncol Biol Phys 1995;33:585-93.
43. Mendenhall WM, Mendenhall CM, Werning JW, et al. Adult head and neck soft tissue sarcomas. Head Neck 2005;27:916-22.
44. Barker JL, Jr, Paulino AC, Feeney S, et al. Locoregional treatment for adult soft tissue sarcomas of the head and neck: an institutional review. Cancer J 2003;9:49-57.
45. Jungu K, Tsujii H, Mizoe J, et al. Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft tissue sarcoma of the head and neck. Int J Radiat Oncol Biol Phys 2012;82:2125-31.
46. Schulz -Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007;25:953-64.
47. Hug EB, Loredo LN, Slater JD, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999;91:432-9.
48. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175:57-63.
49. Noël G, Habrand JL, Jauffret E, et al. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure. Strahlenther Onkol 2003;179:241-8.
50. Igaki H, Tokuuye K, Okumura T, et al. Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 2004;60:1120-6.
51. Ares C, Hug EB, Lomax AJ, et al. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys 2009;75:1111-8.
52. Castro JR, Linstadt DE, Bahary JP, et al. Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys 1994;29:647-55.
53. Schulz-Ertner D, Karger CP, Feuerhake A, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 2007;68:449-57.
54. Mizoe J, Hasegawa A, Takagi R, et al. Carbon ion radiotherapy for skull base chordoma. Skull Base 2009;19:219-24.
55. Koto M, Hasegawa A, Takagi R, et al. Carbon ion radiotherapy for skull base and paracervical tumors. Proceedings of NIRS-ETOILE 2nd Joint Symposium on Carbon Ion Radiotherapy 2011, Centre ETOILE, Lyon, NIRS-M-243; 12-7.
56. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009;27:3290-6.
57. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677-82.
58. Ricardi U, Filippi AR, Guarneri A, et al. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 2009;68:72-7.
59. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303: 1070-6.
60. Bush DA, Slater JD, Shin BB, et al. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 2004;126:1198-203.
61. Iwata H, Murakami M, Demizu Y, et al. High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer. Cancer 2010;116:2476-85.
62. Nihei K, Ogino T, Ishikura S, et al. High-dose proton beam therapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;65:107-11.
63. Nakayama H, Sugahara S, Tokita M, et al. Proton beam therapy for patients with medically inoperable stage I non-small cell lung cancer at the university of Tsukuba. Int J Radiat Oncol Biol Phys 2010;78:467-71.
64. Miyamoto T, Yamamoto N, Nishimura H, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2003;66:127-40.
65. Miyamoto T, Baba M, Yamamoto N, et al. Curative treatment of stage I non-small cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys 2007;67:750-8.
66. Miyamoto T, Baba M, Sugane T, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during one week. J Thorac Oncol 2007;2:916-26.
67. Yamamoto N, Baba M, Nakajima M, et al. Carbon ion radiotherapy in a hypofraction regimen for Stage I non-small cell lung cancer. Proceedings of NIRS-ETOILE 2nd Joint Symposium on Carbon Ion Radiotherapy 2011, Centre ETOILE, Lyon, NIRS-M-243; 27-37.
68. Cancer 'World Health Organization'. February 2006 (retrieved 24 May 2007).
69. The Japan Society of Hepatology. A white paper for the liver cancer. Tokyo: Japan Society of Hepatology; 1999.
70. Bush DA, Hillebrand DJ, Slater JM, Slater JD. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology 2004;127(5 Suppl 1):S189-93.
71. Kawashima M, Furuse J, Nishio T, et al. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 2005;20:1839-46.
72. Chiba T, Tokuuye K, Matsuzaki Y, et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 2005;11:3799-805.
73. Fukumitsu N, Sugahara S, Nakayama H, et al. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2009;74:831-6.
74. Kato H, Tsujii H, Miyamoto T, et al. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 2004;59:1468-76.
75. Kato H, Yamada S, Yasuda S, et al. Four-fraction carbon ion radiotherapy for hepatocellular carcinoma. J Clin Oncol 2004; ASCO Annual Meeting Proceedings (Post-Meeting Edition) 22(14S):4090.
76. Imada H, Kato H, Yasuda S, et al. Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis. Radiother Oncol 2010;96:231-5.
77. Imada H, Yasuda S, Shinoto M, et al. Carbon ion radiotherapy for liver cancer. Proceedings of NIRS-ETOILE 2nd Joint Symposium on Carbon Ion Radiotherapy 2011, Centre ETOILE, Lyon, NIRS-M-243; 46-53.
78. Shipley WU, Verhey LJ, Munzenrider JE, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995;32:3-12.
79. Slater JD, Rossi CJ, Jr, Yonemoto LT, et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 2004;59:348-52.
80. Coote JH, Wylie JH, Cowan RA, et al. Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicity. Int J Radiat Oncol Biol Phys 2009;74:1121-7.
81. Martin JM, Rosewall T, Bayley R, et al. Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Int J Radiat Oncol Biol Phys 2007;69:1084-9.
82. Kupelian PA, Wiloughby TR, Reddy C, et al. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic Experience. Int J Radiat Oncol Biol Phys 2007;68:1424-30.
83. King CR, Brooks JD, Gill H, et al. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 2009;73:1043-8.
84. Michalski JM, Bae K, Roach M, et al. Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study. Int J Radiat Oncol Biol Phys 2010;76:14-22.
85. Schulte RW, Slater JD, Rossi C, et al. Value and perspectives of proton radiation therapy for limited stage prostate cancer. Strahlenther Onkol 2000;176:3-8.
86. Tsuji H, Yanagi T, Ishikawa H, et al. Hypofractionated radiotherapy with carbon ion beams for prostate cancer. Int J Radiat Oncol Biol Phys 2005;63:1153-60.
87. Ishikawa H, Tsuji H, Kamada T, et al. Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study. Radiother Oncol 2006;81:57-64.
88. Tsuji H, Mizoguchi N, Toyama S, et al. Carbon ion radiotherapy for prostate cancer. Proceedings of NIRS-ETOILE 2nd Joint Symposium on Carbon Ion Radiotherapy 2011, Centre ETOILE, Lyon, NIRS-M-243; 66-72.
89. Ishikawa H, Tsuji H, Kamada T, et al. Carbon ion radiotherapy for prostate cancer. Int J Urology 2012;19:296-305.
90. Mack Roach III, Lu J, Pilepich MV, et al. Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials. Int J Radiat Oncol Biol Phys 2000;47:617-27.
91. Tsujii H, Kamada T, Deevus J. Overview of experience with heavier charged particle radiotherapy. In: Delaney TE, Kooy HM, editors. Proton and Charged Particle Therapy. Philadelphia: Lippincott Williams & Wilkins 2008;115-24.
92. DeLaney TF, Kirsch DG. Bone and soft tissue. In: Delaney TE, Kooy HM, editors. Proton and Charged Particle Therapy. Philadelphia: Lippincott Williams & Wilkins 2008;172-85.
93. Kamada T, Tsujii H, Tsuji H, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 2002;22:4472-7.
94. Imai R, Kamada T, Tsuji H, et al. Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas. Proceedings of NIRS-ETOILE 2nd Joint Symposium on Carbon Ion Radiotherapy 2011, Centre ETOILE, Lyon, NIRS-M-243; 38-45.
95. Schoenfeld AJ, Hornicek FJ, Pedlow FX, et al. Osteosarcoma of the spine: experience in 26 patients treated at the Massachusetts General Hospital. Spine J 2010;10:708-14.
96. Ciernik IF, Niemierko A, Harmon DC, et al. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer 2011;117:4522-30.
97. Fuchs B, Hoekzema N, Larson DR, et al. Osteosarcoma of the pelvis: outcome analysis of surgical treatment. Clin Orthop Relat Res 2009;467:510-8.
98. Donati D, Giacomini S, Gozzi E, et al. Osteosarcoma of the pelvis. Eur J Surg Oncol 2004;30:332-40.
99. Ozaki T, Flege S, Kevric M, et al. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study group. J Clin Oncol 2003;21:334-41.
100. Ozaki T, Flege S, Liljenqvist U, et al. Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study group. Cancer 2002;94:1069-77.
101. Ham SJ, Kroon HM, Kroops HS, Hoekstra HJ. Osteosarcoma of the pelvis-oncological results of 40 patients registered by the Netherlands Committee on Bone Tumors. Eur J Surg Oncol 2000;26:53-60.
102. Kawai A, Huvos AG, Meyers PA, Healey JH. Osteosarcoma of the pelvis-oncologic results of 40 patients. Clin Orthop 1998;348:196-207.
103. Matsunobu A, Imai R, Kamada T, et al. Impact of Carbon Ion Radiotherapy for Unresectable Osteosarcoma of the Trunk. Cancer 2012; published online: 22 February 2012. doi:10.1002/cncr.27451.
104. Park L, DeLaney TF, Liebsch NJ, et al. Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys 2006;65:1514-21.
105. Schoenthaler R, Castro JR, Petti PL, et al. Charged particle irradiation of sacral chordoma. Int J Radiat Oncol Biol Phys 1993;26:291-8.
106. Fuchs B, Dickey ID, Yaszemski MJ, et al. Operative management of sacral chordoma. J Bone Joint Surg Am 2005;87:2211-6.
107. Imai R, Kamada T, Tsuji H, et al. Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res 2004;10:5741-6.
108. Imai R, Kamada T, Tsuji H, et al. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials. Int J Radiat Oncol Biol Phys 2010;77:1470-6.
109. Imai R, Kamada T, Sugahara S, et al. Carbon ion radiotherapy for sacral chordoma. Br J Radiol 2011;84:548-54.
110. Kobayashi H, Hashiguchi Y, Ueno H. Follow-up for recurrent colorectal cancer. J Ppn Soci Coloproctology 2006;59:851-6.
111. Sugihara K. Guidelines for Treatment of Recurrent Rectal Cancer. Tokyo: Nankodo Co. Ltd 2003;89-149.
112. Wanebo HJ, Antoniuk P, Koness RJ, et al. Pelvic resection of recurrent rectal cancer. Dis Colon Rectum 1999;42:1438-48.
113. Saito N, Koda K, Takiguchi N, et al. Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 2002;20:192-200.
114. Moriya Y, Akasu T, Fujita S, et al. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 2004;47:2047-54.
115. O'Connel MJ, Child DS, Moertel CG. A prospective controlled evaluation of combined pelvic radiotherapy and methanol extraction residue of BCG for locally unresectable or recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1982;8:1115-9.
116. Wong CS, Cummings BJ, Keane TJ. Combined radiation therapy, mitomycin C, and 5-Fluorouracil for locally recurrent rectal carcinoma. Int J Radiat Oncol Biol Phys 1991;21:1291-6.
117. Lybeert MLM, Martijin H, De Neve W. Radiotherapy for locoregional relapses of rectal carcinoma after initial radical surgery. Int J Radiat Oncol Biol Phys 1992;24:241-6.
118. Yamada S, Shinoto M, Endo S. Carbon ion radiotherapy for patients with locally recurrent rectal cancer. Proceedings of NIRS-ETOILE 2nd Joint Symposium on Carbon Ion Radiotherapy 2011, Centre ETOILE, Lyon, NIRS-M-243; 54-9.
119. Mobaraki A, Ohno T, Yamada S, et al. Cost-effectiveness of carbon ion radiation therapy for locally recurrent rectal cancer. Cancer Sci 2010;101:1834-9.
120. Kato S, Ohno T, Tsujii H, et al. Dose escalation study of carbon ion radiation for locality advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2006;65:388-97.
121. Smith HO, Tiffany MF, Qualls CR, Keys CR. The rising incidence of adenocarcinomas relative to squamous cell carcinomas of the uterine cervix-a 24-year population based study. Gynecol Oncol 2000; 78:97-105.
122. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 2007;297:267-77.
123. Willett CG, Czito BG, Bendell JC, Ryan DP. Locally advanced pancreatic cancer. J Clin Oncol 2005;23:4538-44.
124. Koong AC, Christofferson E, Le Q-T, et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2005;63:320-3.
125. Shinoto M, Yamada S, Yasuda S, et al. Carbon ion radiotherapy for pancreatic cancer. Proceedings of NIRS-ETOILE 2nd Joint Symposium on Carbon Ion Radiotherapy 2011, Centre ETOILE, Lyon, NIRS-M-243; 60-5.
126. Tsuji H, Ishikawa H, Hirasawa H, et al. Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a Phase I/II Dose Escalation Study. Int J Radiat Oncol Biol Phys 2007;67:857-62.
127. Fuss M, Loredo LN, Blacharski PA, et al. Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality. Int J Radiat Oncol Biol Phys 2001;49:1053-9.
128. Hirasawa N, Tsuji H, Ishikawa H, et al. Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram Analysis. Int J Radiat Oncol Biol Phys 2007;67:538-43.